Literature DB >> 11549184

Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice.

Marc J Schultz1, Anita W Rijneveld1, Sandrine Florquin1, Peter Speelman1, Sander J H VAN Deventer1, Tom VAN DER Poll1.   

Abstract

Exotoxin A (P-ExA) is considered to be a major virulence factor of Pseudomonas aeruginosa. Neutrophils, cytokines and nitric oxide (NO) have been implicated as important components of an effective host defence against bacterial respiratory tract infection. To study the role of P-ExA in the pathogenesis of P. aeruginosa pneumonia, C57Bl/6 mice were inoculated intranasally with wild-type PA103 or a mutant P. aeruginosa strain that did not produce P-ExA, PA103-29. P-ExA facilitated the outgrowth of P. aeruginosa in lungs, as reflected by an increasing number of cfu during pneumonia with strain PA103, whereas the number of cfu decreased during pulmonary infection with strain PA103-29. Influx of neutrophils was similar in broncho-alveolar lavage fluids (BALF) during pneumonia with strains PA103 and PA103-29. Lung levels of cytokines (tumor necrosis factor-alpha, interleukin-6) and chemokines (macrophage inflammatory protein-2, KC) were higher in mice inoculated with strain PA103, whereas BALF concentrations of NO were similar in mice treated with strains PA103 and PA103-29. These data suggest that P-ExA impairs host defence during pneumonia caused by P. aeruginosa by a mechanism that does not involve effects on neutrophil influx, cytokines, chemokines or NO formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549184     DOI: 10.1099/0022-1317-50-9-822

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   3.196


  8 in total

Review 1.  Innate immune responses to Pseudomonas aeruginosa infection.

Authors:  Elise G Lavoie; Tamding Wangdi; Barbara I Kazmierczak
Journal:  Microbes Infect       Date:  2011-08-02       Impact factor: 2.700

2.  Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection.

Authors:  Jeevan Jyot; Viviane Balloy; Gregory Jouvion; Amrisha Verma; Lhousseine Touqui; Michel Huerre; Michel Chignard; Reuben Ramphal
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

Review 3.  Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.

Authors:  Shugang Qin; Wen Xiao; Chuanmin Zhou; Qinqin Pu; Xin Deng; Lefu Lan; Haihua Liang; Xiangrong Song; Min Wu
Journal:  Signal Transduct Target Ther       Date:  2022-06-25

4.  Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa.

Authors:  Marc J Schultz; Sylvia Knapp; Sandrine Florquin; Jennie Pater; Kiyoshi Takeda; Shizuo Akira; Tom van der Poll
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

5.  Prophylactic and therapeutic protection of human IgG purified from sera containing anti-exotoxin A titers against pneumonia caused by Pseudomonas aeruginosa.

Authors:  Jin Zhang; Chuang Wan; Bo Yu; Chen Gao; Liqun Zhao; Xin Cheng; Feng Yang; Hao Gu; Quanming Zou; Jiang Gu; Xingyong Wang
Journal:  Hum Vaccin Immunother       Date:  2019-07-09       Impact factor: 4.526

6.  Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa Infection.

Authors:  Mingzi Jiang; Jing Yao; Ganzhu Feng
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.752

Review 7.  Impact of Bacterial Toxins in the Lungs.

Authors:  Rudolf Lucas; Yalda Hadizamani; Joyce Gonzales; Boris Gorshkov; Thomas Bodmer; Yves Berthiaume; Ueli Moehrlen; Hartmut Lode; Hanno Huwer; Martina Hudel; Mobarak Abu Mraheil; Haroldo Alfredo Flores Toque; Trinad Chakraborty; Jürg Hamacher
Journal:  Toxins (Basel)       Date:  2020-04-02       Impact factor: 4.546

Review 8.  Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors.

Authors:  Irene Jurado-Martín; Maite Sainz-Mejías; Siobhán McClean
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.